Neurocrine Bioscience buy Truist Financial Co.
Start price
30.10.25
/
50%
€119.35
Target price
30.10.26
€148.09
Performance (%)
0.00%
Price
30.10.25
€119.35
Summary
This prediction is currently active. Truist_Financial_Co_'s BUY prediction for Neurocrine Bioscience is currently unchanged. This prediction currently runs until 30.10.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | 0.00% |
| iShares Core DAX® | -0.060% |
| iShares Nasdaq 100 | 4.850% |
| iShares Nikkei 225® | 3.504% |
| iShares S&P 500 | 2.820% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its "buy" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $172.00 price target on the stock, up previously from $165.00.
Ratings data for NBIX provided by MarketBeat

